药物治疗：控制糖尿病患者心血管风险行动（ACCORD）血压研究和ACCORD血脂研究：我们能降至多低？ - Suppr

Suppr

超能文献

Pharmacotherapy: ACCORD Blood Pressure and ACCORD Lipid: how low can we go?

作者信息

Glandt Mariela, Raz Itamar

出版信息

Nat Rev Endocrinol. 2010 Sep;6(9):483-4. doi: 10.1038/nrendo.2010.128.

DOI:10.1038/nrendo.2010.128

PMID:20720591

Abstract

摘要

相似文献

Pharmacotherapy: ACCORD Blood Pressure and ACCORD Lipid: how low can we go?药物治疗：控制糖尿病患者心血管风险行动（ACCORD）血压研究和ACCORD血脂研究：我们能降至多低？

Nat Rev Endocrinol. 2010 Sep;6(9):483-4. doi: 10.1038/nrendo.2010.128.

[Combined antihypertensive and antilipemic therapy as one of the pillars in the poly-pharmacologic preventive strategy for patients with high cardiovascular risk].联合抗高血压和抗血脂治疗作为高心血管风险患者多药预防策略的支柱之一

Orv Hetil. 2008 Sep 28;149(39):1827-37. doi: 10.1556/OH.2008.28457.

Fixed drug combination in hypertension and hyperlipidaemia in the developing world.发展中世界高血压和高脂血症的固定剂量复方制剂

Cardiovasc J Afr. 2008 May-Jun;19(3):124-6.

[Hypertension and diabetes - dangerous syntropy].[高血压与糖尿病——危险的协同作用]

MMW Fortschr Med. 2017 Oct;159(18):42-45. doi: 10.1007/s15006-017-0175-4.

Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke.“控制糖尿病患者心血管风险行动”（ACCORD）研究结果一致吗？2型糖尿病患者更低的血压目标除了能减少中风外，并不会导致心血管事件减少。

J Clin Hypertens (Greenwich). 2010 Jul 1;12(7):472-7. doi: 10.1111/j.1751-7176.2010.00333.x.

ADVANCE trial of great importance in preventing cardiovascular deaths in type 2 diabetes.ADVANCE试验在预防2型糖尿病患者心血管死亡方面具有极其重要的意义。

Cardiovasc J Afr. 2007 Sep-Oct;18(5):343-4.

Requirement for hypertension and hyperlipidemia medication in U.S. and Japanese patients with diabetes.美国和日本糖尿病患者对高血压和高脂血症药物的需求。

Am J Med. 2004 Nov 1;117(9):711-2. doi: 10.1016/j.amjmed.2004.06.030.

Drug therapy for hyperlipidemia. When reducing cardiovascular risk is a priority.高脂血症的药物治疗。当降低心血管风险成为首要任务时。

Postgrad Med. 1992 Apr;91(5):162-4, 167-8, 171-2 passim. doi: 10.1080/00325481.1992.11701287.

Blood pressure control in type 2 diabetes.2型糖尿病的血压控制

N Engl J Med. 2010 Aug 12;363(7):695; author reply 697. doi: 10.1056/NEJMc1006411.

Update on Hypertension Management: treatment of hypertension in patients with type 2 diabetes mellitus.高血压管理的最新进展：2型糖尿病患者的高血压治疗

J Hypertens. 2006 Jan;24(1):208-10. doi: 10.1097/01.hjh.0000198038.01387.9b.

本文引用的文献

Effects of combination lipid therapy in type 2 diabetes mellitus.2 型糖尿病的联合降脂治疗效果。

N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Epub 2010 Mar 14.

Effect of valsartan on the incidence of diabetes and cardiovascular events.缬沙坦对糖尿病和心血管事件发生的影响。

N Engl J Med. 2010 Apr 22;362(16):1477-90. doi: 10.1056/NEJMoa1001121. Epub 2010 Mar 14.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.强化血压控制对 2 型糖尿病的影响。

N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.培哚普利与吲达帕胺固定复方制剂对2型糖尿病患者大血管和微血管转归的影响（ADVANCE试验）：一项随机对照试验

Lancet. 2007 Sep 8;370(9590):829-40. doi: 10.1016/S0140-6736(07)61303-8.

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.长期非诺贝特治疗对9795例2型糖尿病患者心血管事件的影响（FIELD研究）：随机对照试验

Lancet. 2005 Nov 26;366(9500):1849-61. doi: 10.1016/S0140-6736(05)67667-2.

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).高危高血压患者随机接受血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗的主要结局：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）

JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981.

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.通过提高高密度脂蛋白胆固醇水平和降低冠状动脉疾病患者的甘油三酯水平进行二级预防。

Circulation. 2000 Jul 4;102(1):21-7. doi: 10.1161/01.cir.102.1.21.

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.强化降压与小剂量阿司匹林对高血压患者的影响：高血压最佳治疗（HOT）随机试验的主要结果。HOT研究组

Lancet. 1998 Jun 13;351(9118):1755-62. doi: 10.1016/s0140-6736(98)04311-6.

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.赫尔辛基心脏研究中血清甘油三酯、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇浓度对冠心病风险的联合影响。对治疗的启示。

Circulation. 1992 Jan;85(1):37-45. doi: 10.1161/01.cir.85.1.37.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验